The aim of this study was to compared effects of Royal jelly with Omega 3 on fatigue and quality of life of multiple sclerosis patients
Design
This study was a double-blind, controlled trial, 33 patients with MS were assigned in each group.For randomization, the permuted block randomization will be used with quadruple blocks, In order to apply the concealment in the randomization process, unique codes, which is generated by the software, will be used on the drug boxes.
Settings and conduct
All patients referred to Imam Golestan Hospital of Ahvaz, Iran, were assigned randomly in one of the treatment regimens for 4 weeks,
Participants/Inclusion and exclusion criteria
Inclusion criteria: MS patients have fatigue; No other neurological disease; No Diseases like diabetes and autoimmune diseases; No new attack in the last month
Exclusion criteria: Emergence of drug side effects; New disease attack; Do not take medicine for one week; Pregnancy
Intervention groups
Intervention group: Interferon (main treatment) with Omega-3 capsules (1 g daily) for one month
Intervention group: Intervention group: Interferon (main treatment) with Royal jelly capsules (1 g daily) for one month
Clinical study of the Royal jelly effect on fatigue and quality of life in patients with multiple sclerosis in compare with Omega-3
Public title
Effect of royal Jelly and Omega-3 in multiple sclerosis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Multiple sclerosis patients have fatigue
Exclusion criteria:
other neurological disease
Diseases like diabetes and autoimmune diseases
new attack in the last month
Emergence of drug side effects
New disease attack
Pregnancy
Age
From 15 years old to 66 years old
Gender
Both
Phase
2-3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Sample size
Target sample size:
66
Randomization (investigator's opinion)
Randomized
Randomization description
For randomization, the permuted block randomization will be used with quadruple blocks. blocks will be produced by using the online site (www.sealedenvelope.com)
Blinding (investigator's opinion)
Double blinded
Blinding description
Unique codes, which is generated by the software, will be used on the drug boxes. By entering each individual into the study based on the produced sequence, the drug box in which the code is registered, will be assigned to the individual. During the research, the randomization list is held by the statistic consultant, and the participants, the project implementer and all those who participate in the measurement of the indicators will not be aware of the assigned groups
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ahvaz Jundishapur University of Medical Sciences
Street address
Golestan Road
City
Ahvaz
Province
Khouzestan
Postal code
6135733184
Approval date
2017-10-07, 1396/07/15
Ethics committee reference number
IR.AJUMS.REC.1396.493
Health conditions studied
1
Description of health condition studied
Multiple sclerosis
ICD-10 code
G35
ICD-10 code description
Multiple sclerosis
2
Description of health condition studied
Neurasthenia
ICD-10 code
F48.0
ICD-10 code description
Neurasthenia
Primary outcomes
1
Description
Fatigue
Timepoint
Start intervention and a month later
Method of measurement
MFIS questionnaire
2
Description
Quality of Life
Timepoint
Start intervention and a month later
Method of measurement
MSQL-54 questionnaire
3
Description
Blood parameters
Timepoint
MSQL-54 questionnaire
Method of measurement
Blood laboratory analysis
Secondary outcomes
1
Description
Side effects
Timepoint
One month after the intervention began
Method of measurement
Observation
Intervention groups
1
Description
Intervention group: Interferon (main treatment) with Omega-3 capsules (1 g daily) for one month
Category
Treatment - Drugs
2
Description
Intervention group: Intervention group: Interferon (main treatment) with Royal jelly capsules (1 g daily) for one month
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Golestan Hospital in Ahvaz
Full name of responsible person
Amir Siahpoosh
Street address
Medicinal Plants Research Center and Deparment of Pharmacognosy, Faculty of Pharmacy, Ahvaz Jundishapur University of medical Sciences, Ahvaz, Iran
City
Ahvaz
Province
Khouzestan
Postal code
6135733118
Phone
+98 61 3374 3001
Email
golestanhospital@ajums.ac.ir
Web page address
http://golestan.ajums.ac.ir/rha/mataleb/dasteh/39
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center
Full name of responsible person
Dr Mohamad badavi
Street address
Ahvaz golestan road
City
ahvaz
Province
Khouzestan
Postal code
6135733184
Phone
+98 61 3336 2414
Email
amirsiahpoosh@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Amir Siahpoosh
Position
Assaciate professor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Golestan road
City
ahvaz
Province
Khouzestan
Postal code
6155883964
Phone
+98 61 3334 2197
Fax
Email
siahpoosh-a@ajums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Amir Siahpoosh
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Golestan road
City
Ahvaz
Province
Khouzestan
Postal code
6135733184
Phone
+98 61 3334 2197
Fax
Email
siahpoosh-a@ajums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Amir Siahpoosh
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Golestan road
City
Ahvaz
Province
Khouzestan
Postal code
6135733184
Phone
+98 61 3334 2197
Fax
Email
siahpoosh-a@ajums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
Only a part of the data will be shared
When the data will become available and for how long
Only a part of the data will be shared
To whom data/document is available
The access period will be 6 months after the publication of the results
Under which criteria data/document could be used
Six months after the publication of this study papers, the obtained data will be available to the applicant researchers for further analysis
From where data/document is obtainable
Applicants can be contacted with corresponding author by e-mail
What processes are involved for a request to access data/document
Applicants will be able to access the obtained data from current study by sending an email to the corresponding author up to one month